Neonatal dexamethasone on day 7 causes mild hyperactivity and cerebellar stunting.

Neurotoxicol Teratol

Division of Reproductive & Developmental Toxicology, National Center for Toxicological Research/FDA, Jefferson, AR 72079, USA.

Published: April 1999

To investigate the effects of glucocorticoid treatment on central nervous system development, rats were injected with dexamethasone (DEX) (1-3 mg/kg) on postnatal day (PND) 3 or 7. DNA and protein content and concentration were measured in the cerebellum and hippocampus on PND 28 and 112. Whole and regional brain weights were measured at PND 28, 84, and 112. Nest odor preference (PND 10-11), open field activity (PND 18-21), running wheel activity (PND 50-56), and complex maze performance (PND 60-63) were measured in rats treated twice with 1.5 mg/kg DEX on PND 7. DEX treatment on PND 7 resulted in reductions in PND 28 whole brain and regional weights (frontal cortex, cerebellum, and brain stem) and, by PND 112, all except whole brain and cerebellar weights had recovered. A mild syndrome of hyperactivity (increased open field rearing and activity) was apparent in rats treated with DEX on PND 7. These results are discussed in terms of the developmental stage specificity in production of brain, and, specifically, cerebellar insults and their resulting effects.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0892-0362(98)00029-4DOI Listing

Publication Analysis

Top Keywords

pnd
12
pnd 112
12
open field
8
activity pnd
8
rats treated
8
dex pnd
8
brain cerebellar
8
brain
5
neonatal dexamethasone
4
dexamethasone day
4

Similar Publications

Background: Obesity, a rising global health issue, is linked to numerous disorders, including cognitive impairment.

Objectives: This study investigates the effects of coenzyme Q10 (Co-Q10) on cognitive performance, antioxidant defense, cholinergic activity, and hippocampal neuron damage in rats rendered obese by monosodium glutamate (MSG) exposure.

Methods: Forty-eight neonatal male Wistar rats were randomly assigned to one of four groups: Control, MSG, MSG + Q10-10, and MSG + Q10-20.

View Article and Find Full Text PDF

Deficient nitric oxide (NO) signaling plays a critical role in the pathogenesis of bronchopulmonary dysplasia (BPD); however, clinical trials of inhaled NO (iNO) as preventive therapy for BPD have shown little to no benefit. A biochemical obstacle to effective NO-based therapy relates to the high reactivity of NO, potentially leading to harmful oxidation and nitration. Hypothesizing that nitrite-based therapy has less potential to produce adverse reactions, we compared the preventive effects of sodium nitrite (NaNO) and iNO on lung morphology, NO content and signaling, S-nitrosothiols (SNOs) and tyrosine nitration in a novel rat model of experimental BPD.

View Article and Find Full Text PDF

Traditionally, postnatal depression (PND) has been considered as depression in the first year after giving birth, although it has been argued that the 12-month cut-off may be somewhat arbitrary. Specialist perinatal mental health services in England have recently been extended to include women in their second year postpartum; however, there is no good estimate for the prevalence of PND beyond the first year. This review aimed to obtain the best estimate of the prevalence of PND in the second postpartum year.

View Article and Find Full Text PDF

Using estrogen and progesterone to treat premenstrual dysphoric disorder, postnatal depression and menopausal depression.

Front Pharmacol

February 2025

Department of Psychiatry, HER Centre Australia, The School of Translational Medicine, Monash University, Melbourne, VIC, Australia.

Female gonadal hormones, particularly estrogen and progesterone, are not only central to reproductive health but also play a crucial role in regulating mood, cognition, and overall brain health. These hormones have a significant impact on the central nervous system, influencing key processes such as neurotransmission, neuroplasticity, and brain development. Increasing evidence shows that hormonal fluctuations contribute to the onset and progression of mental health disorders that disproportionately affect women, particularly premenstrual dysphoric disorder (PMDD), postnatal depression (PND), and menopausal depression.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!